Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (Q53245769)
Jump to navigation
Jump to search
scientific article published on 16 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. |
scientific article published on 16 September 2015 |
Statements
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (English)
1 reference
Gilles Montalescot
1 reference
A Michael Lincoff
1 reference
Steven E Nissen
1 reference
Stephen J Nicholls
1 reference
Philip J Barter
1 reference
H Bryan Brewer
1 reference
Keith A A Fox
1 reference
C Michael Gibson
1 reference
Christopher Grainger
1 reference
Venugopal Menon
1 reference
Daniel Rader
1 reference
Alan R Tall
1 reference
Ellen McErlean
1 reference
Jeffrey Riesmeyer
1 reference
Burkhard Vangerow
1 reference
Giacomo Ruotolo
1 reference
Govinda J Weerakkody
1 reference
16 September 2015
1 reference
170
1 reference
6
1 reference
1061-1069
1 reference
Identifiers
1 reference